New report highlights pregabalin trafficking as a major concern

The medicine pregabalin is fast becoming an emerging point of concern in the Niger and other parts of West Africa, a UNODC report highlights.

According to a recent report published by the United Nations Office on Drugs and Crime (UNODC), it is emerging that pregabalin trafficking in the Niger and other parts of West Africa is fast becoming a major concern for the region.

The report highlights that the Sahel has had to contend with trafficking rings surrounding not only pregabalin but also pharmaceutical opioids like tramadol, as well as cocaine and cannabis resin.

These four substances have been classified in the report as the most internationally trafficked drugs seized in the region.

About pregabalin

Pregabalin is a gabapentinoid used in the management of diabetic peripheral neuropathic pain, partial-onset seizures, postherpetic neuralgia, fibromyalgia, and neuropathic pain with spinal cord injury.1

This drug functions as a gamma-aminobutyric acid (GABA) analogue, binding to the alpha-2-delta subunit of voltage-gated calcium channels and decreasing calcium influx and neurotransmitter release.

This enables the drug to produce antinociceptive, anticonvulsant, and anxiolytic effects and to also treat a variety of off-label indications.

In pain management, particularly chronic low back or radicular pain, there has been an observed increase in off-label management despite a lack of evidence of the efficacy of the same.2

READ ALSO: Using AI to tailor drugs for Africa (

Pregabalin in the Niger and parts of West Africa

The Republic of the Niger, at 480,000 sq mi, is the largest country in West Africa and has had its fair share of pregabalin trafficking seizures.

See the table below for a summary of some pregabalin seizures in the country and other parts of the region.

CountryYearQuantity of pregabalin seizedCity
Republic of the Niger2021150,000 tabletsAgadez
 300,000 capsulesZinder
2022158 tabletsAgadez
 112,514 capsulesMaradi
 30,000 capsulesZinder
2023390,000 capsulesOn-transit pick up vehicle
Togo20225,974,500 tabletsPort of Lomé
Nigeria2022150,000 tablets 
Algeria202220,180 tablets 
Table showing the number of pregabalin seizures in the Niger and other countries in Africa
Why pregabalin?

The key motivator for those who abuse pregabalin is a feeling of euphoria.

Additionally, studies have shown that those who take the drug for recreational purposes have been quoted as describing the feelings they experience as sedation, dissociation, relaxation, contentment, numbness, uninhibited behavior, improved sociability, empathy, or audio/visual hallucinations.3

Other studies have shown that many misuse pregabalin by self-medicating with the intention of fighting anxiety or managing pain.4

It has also been reported to be used to heighten the effects of other substances, such as opioids.

Effects of misuse

Pregabalin carries a risk of dependence, an aspect that may introduce the classic addiction-related issues.

In addition, drug-drug interactions, particularly with medicines such as methadone or morphine, could lead to death due to breathing complications.

Looking at the numbers in England, Scotland, and Wales, for example, there were a total of 808 deaths related to pregabalin in the year 2022 alone.5

Australia had 824 deaths related to the same drug.

And there are an estimated thousands of unreported deaths globally.


Compared to the US and some European countries where pregabalin has been listed as a high-risk potent drug in their laws, the case is not the same as in the Niger and other African countries.

This means the handling and distribution of this drug are not under stringent guidelines.

Due to this circumstance, traffickers are able to evade domestic laws, and it is more challenging for law enforcement to look into and apprehend those involved in the trafficking of pregabalin.


Pregabalin is a key medicine, and doctors would argue that it can’t be completely eliminated from standard therapy. However, this doesn’t mean stakeholders should sit idly by as actions that promote misuse and abuse thrive.

Trafficking of this medicine as well as pharmaceutical opioids is both a global and African problem.

It is therefore important to implement strategies that will limit the enablers of this practice.

The UNODC report highlights corruption and money laundering as the main enablers of this practice, as well as the lack of proper laws that would inhibit misuse and abuse of the same.

It may be time to step up efforts in the fight against pregabalin trafficking.

Almost as much as that exerted in the fight against cocaine, cannabis, and opioid trafficking.

Do you find this insightful? Subscribe for more.


1.       Lyrica (pregabalin) dosing, indications, interactions, adverse effects, and more. Accessed May 6, 2024.

2.       Folia. CBIP. Accessed May 6, 2024.

3.       Patterns of gabapentin and pregabalin use and misuse: Results of a population‐based cohort study in France – Driot – 2019 – British Journal of Clinical Pharmacology – Wiley Online Library. Accessed May 6, 2024.

4.       Servais L, Huberland V, Richelle L. Misuse of Pregabalin: a qualitative study from a patient’s perspective. BMC Public Health. 2023;23(1):1339. doi:10.1186/s12889-023-16051-6

5.       Death registrations related to Gabapentin or Pregabalin, England and Wales: 2018 and 2022 – Office for National Statistics. Accessed May 6, 2024.


Haleon shares

GSK raises £1.25 billion from discounted sale of Haleon shares

APR TeamMay 17, 20242 min read

Listen to this article What happened? On Thursday, May 17, 2024, GSK announced its plans to sell an estimated 385 million Haleon shares, representing its final 4.2% stake that it held in its former consumer goods division. Today, the British pharma giant has made good of its intentions. GSK has confirmed the sale of its remaining stake in Haleon for £1.25 billion ($1.58 billion), thereby concluding its gradual divestment of…

African Medicines Agency

New Nation Has Officially Ratified The African Medicines Agency Treaty

Bevin LikuyaniMay 16, 20244 min read

Listen to this article What happened? On May 15th, 2024, the Republic of Cote d’Ivoire achieved a significant milestone by depositing their instrument of ratification for the Treaty establishing the African Medicines Agency (AMA). This development marks another significant achievement…

NAFDAC boss: How local production is the answer to high cost of medicines

NAFDAC boss: How local production is the answer to high cost of medicines

Bevin LikuyaniMay 8, 20244 min read

Listen to this article Prof. Mojisola Adeyeye, Director General, National Agency for Food and Drug Administration and Control (NAFDAC), has reiterated her (and the agency’s) commitment to mitigating the prevailing high cost of medicines in Nigeria. Speaking at a webinar…

meningitis vaccine

Nigeria sets pace with rollout of new meningitis vaccine

APR TeamApr 15, 20243 min read

Image source: Getty Images In a momentous move, Nigeria has launched a novel WHO-recommended meningitis vaccine against Meningococcus bacteria. Making it the first nation to do so globally. The jab, named Men5CV, is effective against the 5 main strains of…

Translate »